Cognition Therapeutics Overview
- Founded
- 2007

- Status
- Private
- Employees
- 27

- Latest Deal Type
- Grant
- Latest Deal Amount
- $80M

- Investors
- 31
Cognition Therapeutics General Information
Description
Developer of small molecule drugs designed to treat people with central nervous system disorders like Alzheimer's disease, dementia with Lewy bodies (DLB), and Parkinson's disease. The company's drug candidates target the sigma-2 receptor complex, a key protein regulator, which prevents the binding of toxic proteins to their synaptic receptors thereby preserving brain health, enabling physicians to treat CNS diseases such as Alzheimer's and Parkinson's.
Contact Information
- 2403 Sidney Street
- Pittsburgh, PA 15203
- United States
Cognition Therapeutics Timeline
Cognition Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
19. Grant | 08-Jun-2020 | $80M | 000.00 | Completed | Clinical Trials - Phase 2 | |
18. Debt - PPP | 11-Apr-2020 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
17. Later Stage VC | 31-Mar-2020 | 000.00 | Completed | Clinical Trials - Phase 2 | ||
16. Grant | 21-Jun-2019 | 00.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
15. Later Stage VC | 27-Nov-2018 | 00.000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
14. Grant | 08-Sep-2018 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
13. Grant | 16-Apr-2018 | 00.000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
12. Grant | 18-Sep-2017 | 00.000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
11. Later Stage VC (Series B) | 30-Nov-2016 | $6.5M | $24.6M | 0000 | Completed | Clinical Trials - General |
10. Grant | 29-Sep-2016 | $24.6M | Completed | Clinical Trials - General |
Cognition Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A2 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series A1 | 3,970,776 | $0.001000 | 8% | $0.69 | $0.69 | 1x | $0.69 | 9.86% |
Series A | 3,067,519 | $0.001000 | 8% | $0.69 | $0.69 | 1x | $0.69 | 7.62% |
Cognition Therapeutics Comparisons
Industry
000000 0
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCognition Therapeutics Competitors (50)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cadent Therapeutics | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 000000&0 | 000.00 |
00000000 000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
0000 000000 | Formerly VC-backed | San Diego, CA | 00 | 00000 | 00000000 | 00000 |
000 000000 | Venture Capital-Backed | Boston, MA | 0 | 000.00 | 0000000000 0 | 000.00 |
0000000 | Venture Capital-Backed | Framingham, MA | 00 | 0000 | 0000000000 | 0000 |
Cognition Therapeutics Executive Team (10)
Cognition Therapeutics Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Aaron Fletcher Ph.D | Bios Partners | Board Member | 000 0000 |
Brett Monia Ph.D | Self | Board Member | 000 0000 |
Irwin Scher MD | Self | Board Member | 000 0000 |
Jack Khattar | Self | Board Member | 000 0000 |
Mark Breedlove | Self | Board Member | 000 0000 |
Cognition Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCognition Therapeutics Investors (31)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Atlanta Technology Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
Audrey's Kitchen | Family Office | 000 0000 | 000000 0 | ||
Next Act Fund | Angel Group | 000 0000 | 000000 0 | ||
National Institute On Aging | Government | 000 0000 | 000000 0 | ||
Sofia Fund | Angel Group | Minority | 000 0000 | 000000 0 |